Ketamine Wellness Centers (KWC) Announces Grand Opening of Salt Lake City Clinic
Delic Holdings Corp announced the opening of its first ketamine clinic in Utah, located in Salt Lake City, through its subsidiary, Ketamine Wellness Centers (KWC). This clinic is set to be one of the largest in the U.S., comprising seven treatment rooms and creating ten new jobs. KWC aims to address the high rates of mental health concerns in Utah by providing accessible, effective treatments for conditions like depression and PTSD. The clinic marks a strategic expansion for Delic, enhancing its network of 11 clinics across nine states and building on its commitment to affordable mental health care.
- Opening of the first ketamine clinic in Utah expands Delic's network, supporting underserved communities.
- KWC Salt Lake City will create 10 new jobs, boosting local employment.
- The clinic aims to provide effective treatments for high mental health issues in Utah.
- None.
Salt Lake City location is the first in Utah and one of the largest ketamine clinics in the U.S., expands Delic's network of clinics
VANCOUVER, BC, Jan. 11, 2022 /PRNewswire/ - Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), a leader in new medicines and treatments for a modern world, today announced its subsidiary, Ketamine Wellness Centers (KWC), has officially expanded operations into Utah with the opening of its Salt Lake City location. KWC was acquired by Delic in September 2021 and currently operates 11 ketamine infusion treatment clinics across nine states, delivering more than 61,000 treatments to date.
Located in the suburb of Taylorsville at 6087 South Redwood Road, Suite B, KWC Salt Lake City is the first of the company's clinics in Utah. With up to seven treatment rooms at the facility, this location will be one of the largest ketamine clinics in the U.S. and the largest ketamine infusion clinic in Utah. The clinic will also create 10 new jobs, with four filled at the outset and an additional six with a full patient schedule.
"Utah currently experiences one of the highest rates of mental health concerns in the country with lower access to care, and KWC aims to serve this new community of patients struggling with treatment-resistant conditions," said Kevin Nicholson, CEO of KWC and Chief Operating Officer for Delic. "KWC is known for providing the highest standard of care and we are committed to providing the most effective and personalized treatment protocol to our patients and support and education to their loved ones."
The launch of KWC Salt Lake City allows Delic to execute its strategy of opening ketamine treatment centers in growing cities with the goal of reaching the greatest number of patients and providing reasonably priced treatments.
Matt Stang, co-founder and CEO of Delic, explained, "As the pandemic enters its third year, the need for effective, affordable options for mental health treatments is even more critical. We are thrilled to be opening the first KWC clinic in Utah and building on our promise to make these vital treatments more accessible by expanding our network into underserved communities where they are most needed."
To commemorate the grand opening, KWC Salt Lake City will host several events for the community to learn more about the clinic and ask questions about ketamine treatments, including an in-person and virtual meet and greet and a spring event that will bring together other local businesses.
For more information about Ketamine Wellness Centers' locations, services and hours of operation, please visit https://www.ketaminewellnesscenters.com/locations/.
About Ketamine Wellness Centers
Ketamine Wellness Centers (KWC) is the largest ketamine therapy provider in the United States with 11 clinic locations serving communities across nine states. Since 2011 KWC has been a trusted leader in bringing IV ketamine therapy into mainstream health care. KWC has provided over 60,000 treatments to clinically eligible patients, from young adults to seniors, in addition to developing specialized programs for veterans and first responders. The KWC team, including a core group of physicians, psychologists, clinicians, and executives, is dedicated to providing value-based, personalized, clinically controlled ketamine infusion care for people suffering from treatment-resistant depression, anxiety, PTSD, OCD and chronic pain. KWC's scalable business and treatment model is designed for further rapid expansion along with breakthrough innovations in effective therapies and services.
About Delic Corp
Delic is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics. The company owns and operates an umbrella of related businesses, including the largest chain of psychedelic wellness clinics in the country, including Ketamine Infusion Centers and Ketamine Wellness Centers; the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology, Delic Labs; the premier psychedelic wellness event, Meet Delic; and trusted media and e-commerce platforms Reality Sandwich and Delic Radio. Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and effective treatment options to the masses.
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and does not accept responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws and may not be offered or sold within the United Statesunless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
Forward-Looking Information and Statements
This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Delic's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements contained herein may include, but are not limited to: information regarding the timing or terms upon which the Transaction will be completed; potential benefits of the Transaction; anticipated continued growth in the health and wellness sector (and, in particular, related to psychedelics); the ability of Delic to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.
By identifying such information and statements in this manner, Delic is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Delic to be materially different from those expressed or implied by such information and statements. Such risks and other factors may include, but are not limited to: risks and uncertainties relating to the Transaction not closing as planned or at all or on terms and conditions set forth in the Merger Agreement; incorrect assessment of the value and potential benefits of the Transaction; direct and indirect material adverse effects from the COVID-19 pandemic; inability to obtain future financing on suitable terms; failure to obtain required regulatory and other approvals; risks inherent in the psychedelic treatment sector; changes in applicable laws and regulations; and failure to comply with applicable laws and regulations.
In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Delic has made certain assumptions. These assumptions include, but are not limited to: assumptions as to the time required to negotiate a definite agreement and complete matters related to the Transaction; the ability to consummate the Transaction; the ability of the parties to obtain, in a timely manner, the requisite regulatory, corporate and other third party approvals and the satisfaction of other conditions to the consummation of the Transaction on the proposed terms; the potential impact of the announcement or consummation of the Transaction on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time on the Transaction.
Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
Although Delic believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Delic does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to Delic or persons acting on its behalf is expressly qualified in its entirety by this notice.
View original content to download multimedia:https://www.prnewswire.com/news-releases/ketamine-wellness-centers-kwc-announces-grand-opening-of-salt-lake-city-clinic-301455112.html
SOURCE Delic Holdings Inc.
FAQ
What is the significance of DELCF's new clinic opening in Salt Lake City?
How many jobs will the new KWC Salt Lake City clinic create?
What conditions does Ketamine Wellness Centers aim to treat?
